252 related articles for article (PubMed ID: 26647050)
1. High-Throughput Raman Spectroscopy Screening of Excipients for the Stabilization of Amorphous Drugs.
Chen X; Stoneburner K; Ladika M; Kuo TC; Kalantar TH
Appl Spectrosc; 2015 Nov; 69(11):1271-80. PubMed ID: 26647050
[TBL] [Abstract][Full Text] [Related]
2. Mitigating unwanted amorphisation: A screening method for the selection of suitable excipients.
Amharar Y; Curtin V; Gallagher KH; O'Siochru E; O'Connell P; Healy AM
Eur J Pharm Sci; 2016 Jan; 81():181-8. PubMed ID: 26493586
[TBL] [Abstract][Full Text] [Related]
3. Quantitative polymorph contaminant analysis in tablets using Raman and near infra-red spectroscopies.
Hennigan MC; Ryder AG
J Pharm Biomed Anal; 2013 Jan; 72():163-71. PubMed ID: 23146243
[TBL] [Abstract][Full Text] [Related]
4. A comparison of alternative polymer excipients and processing methods for making solid dispersions of a poorly water soluble drug.
Broman E; Khoo C; Taylor LS
Int J Pharm; 2001 Jul; 222(1):139-51. PubMed ID: 11404040
[TBL] [Abstract][Full Text] [Related]
5. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
[TBL] [Abstract][Full Text] [Related]
6. Glass Transition Dynamics and Physical Stability of Amorphous Griseofulvin in Binary Mixtures with Low-
Tu W; Knapik-Kowalczuk J; Chmiel K; Paluch M
Mol Pharm; 2019 Aug; 16(8):3626-3635. PubMed ID: 31287704
[TBL] [Abstract][Full Text] [Related]
7. Amino acids as co-amorphous stabilizers for poorly water-soluble drugs--Part 2: molecular interactions.
Löbmann K; Laitinen R; Strachan C; Rades T; Grohganz H
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):882-8. PubMed ID: 23567485
[TBL] [Abstract][Full Text] [Related]
8. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
Caron V; Tajber L; Corrigan OI; Healy AM
Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
[TBL] [Abstract][Full Text] [Related]
9. Solid dispersion prepared by continuous cogrinding in an air jet mill.
Muehlenfeld C; Kann B; Windbergs M; Thommes M
J Pharm Sci; 2013 Nov; 102(11):4132-9. PubMed ID: 24105729
[TBL] [Abstract][Full Text] [Related]
10. The formation and physical stability of two-phase solid dispersion systems of indomethacin in supercooled molten mixtures with different matrix formers.
Semjonov K; Kogermann K; Laidmäe I; Antikainen O; Strachan CJ; Ehlers H; Yliruusi J; Heinämäki J
Eur J Pharm Sci; 2017 Jan; 97():237-246. PubMed ID: 27890595
[TBL] [Abstract][Full Text] [Related]
11. Influence of Low-Molecular-Weight Excipients on the Phase Behavior of PVPVA64 Amorphous Solid Dispersions.
Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
Pharm Res; 2018 Jan; 35(1):25. PubMed ID: 29305717
[TBL] [Abstract][Full Text] [Related]
12. Real time Raman imaging to understand dissolution performance of amorphous solid dispersions.
Tres F; Treacher K; Booth J; Hughes LP; Wren SA; Aylott JW; Burley JC
J Control Release; 2014 Aug; 188():53-60. PubMed ID: 24910191
[TBL] [Abstract][Full Text] [Related]
13. High-throughput kinetic turbidity analysis for determination of amorphous solubility and excipient screening for amorphous solid dispersions.
Fan Y; Castleberry S
Int J Pharm; 2023 Jan; 631():122495. PubMed ID: 36526147
[TBL] [Abstract][Full Text] [Related]
14. Better understanding of dissolution behaviour of amorphous drugs by in situ solid-state analysis using Raman spectroscopy.
Savolainen M; Kogermann K; Heinz A; Aaltonen J; Peltonen L; Strachan C; Yliruusi J
Eur J Pharm Biopharm; 2009 Jan; 71(1):71-9. PubMed ID: 18590816
[TBL] [Abstract][Full Text] [Related]
15. Influence of copolymer composition on the phase behavior of solid dispersions.
Prudic A; Kleetz T; Korf M; Ji Y; Sadowski G
Mol Pharm; 2014 Nov; 11(11):4189-98. PubMed ID: 25295846
[TBL] [Abstract][Full Text] [Related]
16. Raman spectroscopy for the in-line polymer-drug quantification and solid state characterization during a pharmaceutical hot-melt extrusion process.
Saerens L; Dierickx L; Lenain B; Vervaet C; Remon JP; De Beer T
Eur J Pharm Biopharm; 2011 Jan; 77(1):158-63. PubMed ID: 20933084
[TBL] [Abstract][Full Text] [Related]
17. Lean Raman imaging for rapid assessment of homogeneity in pharmaceutical formulations.
Brown SC; Claybourn M; Sievwright D; Fearnside V; Ashman C
Appl Spectrosc; 2010 Apr; 64(4):442-7. PubMed ID: 20412630
[TBL] [Abstract][Full Text] [Related]
18. Amino acids as co-amorphous excipients for simvastatin and glibenclamide: physical properties and stability.
Laitinen R; Löbmann K; Grohganz H; Strachan C; Rades T
Mol Pharm; 2014 Jul; 11(7):2381-9. PubMed ID: 24852326
[TBL] [Abstract][Full Text] [Related]
19. Emerging trends in the stabilization of amorphous drugs.
Laitinen R; Löbmann K; Strachan CJ; Grohganz H; Rades T
Int J Pharm; 2013 Aug; 453(1):65-79. PubMed ID: 22569230
[TBL] [Abstract][Full Text] [Related]
20. Vapor Phase Alkyne Coating of Pharmaceutical Excipients: Discrimination Enhancement of Raman Chemical Imaging for Tablets.
Yamashita M; Sasaki H; Moriyama K
J Pharm Sci; 2015 Dec; 104(12):4093-4098. PubMed ID: 26343262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
